agonist-bound structure human p2y12 receptor 
p2y12 receptor p2y12r one eight members p2yr family expressed humans one prominent clinical drug targets inhibition platelet aggregation although mutagenesis modelling studies p2y12r provided useful insights ligand binding1- agonist antagonist recognition function p2y12r remain poorly understood molecular level report structures human p2y12r complex full agonist -methylthio-adenosine--diphosphate 2mesadp close analogue endogenous agonist adp angstrom resolution corresponding atp derivative -methylthio-adenosine--triphosphate 2mesatp angstrom resolution structures together structure p2y12r antagonist ethyl --benzylsulfonyl carbamoylpiperidin--yl--cyano--methylnicotinate azd12835 reveal striking conformational changes nucleotide non-nucleotide ligand complexes extracellular regions analysis changes provides insight distinct ligand binding landscape inthed-group class ag-protein-coupled receptors gpcrs agonist non-nucleotide antagonist adopt different orientations p2y12r partially overlapped binding pockets agonist-bound p2y12r structure answers long-standing questions surrounding p2y12r-agonist recognition reveals interactions several residues reported involved agonist binding first example knowledge gpcr agonist access binding pocket requires large-scale rearrangements highly malleable extracellular region structural docking studies will therefore provide invaluable insight pharmacology mechanisms action agonists different classes antagonists p2y12r potentially closely related p2yrs 
